# Evaluation of Topical Rebamipide Versus Topical Betamethasone for Management of Oral Ulcers in Behcet's Disease

> **NCT06084624** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Cairo University** · enrollment: 40 (estimated)

## Conditions studied

- Oral Ulceration Due to Behçet's Disease

## Interventions

- **DRUG:** Rebamipide mouthwash
- **DRUG:** Betamethasone mouthwash

## Key facts

- **NCT ID:** NCT06084624
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12
- **Primary completion:** 2025-01
- **Final completion:** 2025-04
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06084624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06084624, "Evaluation of Topical Rebamipide Versus Topical Betamethasone for Management of Oral Ulcers in Behcet's Disease". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06084624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*